{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:18Z","timestamp":1790610798394,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11060-026-05652-x","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:14:15Z","timestamp":1780488855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A comparative study of Ommaya reservoir versus lumbar puncture for intrathecal chemotherapy in patients with leptomeningeal metastasis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"178","author":[{"given":"Lushao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuechao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pokharel","family":"Bihani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazmi Sabrina","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Xuan","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangdong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"3","key":"5652_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02341153","volume":"9","author":"JG Kaplan","year":"1990","unstructured":"Kaplan JG, DeSouza TG, Farkash A, Shafran B, Pack D, Rehman F, Fuks J, Portenoy R (1990 Dec) Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 9(3):225\u2013229","journal-title":"J Neurooncol"},{"issue":"18","key":"5652_CR2","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","volume":"74","author":"JL Clarke","year":"2010","unstructured":"Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM (2010 May 4) Leptomeningeal metastases in the MRI era. Neurology 74(18):1449\u20131454","journal-title":"Neurology"},{"key":"5652_CR3","doi-asserted-by":"crossref","unstructured":"Wasserstrom WR, Glass JP, Posner JB (1982 Feb 15) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49(4):759\u2009\u2013\u200972","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7"},{"key":"5652_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2022.09.013","volume":"174","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yang X, Li NJ, Xue JX (2022 Dec) Leptomeningeal metastases in non-small cell lung cancer: diagnosis and treatment. Lung Cancer 174:1\u201313","journal-title":"Lung Cancer"},{"key":"5652_CR5","doi-asserted-by":"crossref","unstructured":"Thakkar JP, Kumthekar P, Dixit KS, Stupp R, Lukas RV (2020 Apr 15) Leptomeningeal metastasis from solid tumors. J Neurol Sci 411:116706","DOI":"10.1016\/j.jns.2020.116706"},{"issue":"2","key":"5652_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jns.2004.05.008","volume":"223","author":"U Herrlinger","year":"2004","unstructured":"Herrlinger U, F\u00f6rschler H, K\u00fcker W, Meyermann R, Bamberg M, Dichgans J, Weller M (2004 Aug 30) Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 223(2):167\u2013178","journal-title":"J Neurol Sci"},{"key":"5652_CR7","doi-asserted-by":"crossref","unstructured":"Le Emilie BJ, Pentsova E, Preusser M, Weller M, Boire A (2025 Oct 14) Point\/Counterpoint: intrathecal therapy for patients with leptomeningeal metastases from solid tumors. Neuro Oncol 27(9):2225\u20132231","DOI":"10.1093\/neuonc\/noaf126"},{"issue":"4","key":"5652_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJM197507242930402","volume":"293","author":"WR Shapiro","year":"1975","unstructured":"Shapiro WR, Young DF, Mehta BM (1975 July 24) Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 293(4):161\u2013166","journal-title":"N Engl J Med"},{"issue":"18","key":"5652_CR9","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1200\/jco.2006.24.18_suppl.1530","volume":"24","author":"MJ Glantz","year":"2006","unstructured":"Glantz MJ, Chamberlain MC, Batchelor T, Eric W, Cavalli F, Shapiro WR (2006 Jun) Interaction between route of intra-CSF chemotherapy administration and efficacy of therapy in patients with neoplastic meningitis. J Clin Oncol 24(18):1530\u20131530","journal-title":"J Clin Oncol"},{"key":"5652_CR10","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021 Mar 29) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"key":"5652_CR11","doi-asserted-by":"publisher","unstructured":"Higgins JPT, Morgan RL, Rooney AA, Taylor KW, Thayer KA, Silva RA, Lemeris C, Akl EA, Bateson TF, Berkman ND, Glenn BS, Hr\u00f3bjartsson A, LaKind JS, McAleenan A, Meerpohl JJ, Nachman RM, Obbagy JE, O\u2019Connor A, Radke EG, Savovi\u0107 J, Sch\u00fcnemann HJ, Shea B, Tilling K, Verbeek J, Viswanathan M, Sterne JAC (2024) A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ Int 186:108602. Available at: https:\/\/doi.org\/10.1016\/j.envint.2024.108602","DOI":"10.1016\/j.envint.2024.108602"},{"key":"5652_CR12","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007 Jun 7) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16"},{"key":"5652_CR13","doi-asserted-by":"crossref","unstructured":"Parmar MK, Torri V, Stewart L (1998 Dec 30) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17(24):2815\u20132834","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8"},{"issue":"4","key":"5652_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/oxfordjournals.annonc.a059187","volume":"6","author":"M Iacoangeli","year":"1995","unstructured":"Iacoangeli M, Roselli R, Pagano L, Leone G, Marra R, Pompucci A, Trignani R, Scerrati M (1995) Intrathecal chemotherapy for treatment of overt meningeal leukemia: comparison between intraventricular and traditional intralumbar route. Ann Oncol 6(4):377\u2013382","journal-title":"Ann Oncol"},{"issue":"10","key":"5652_CR15","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","volume":"5","author":"RN Hitchins","year":"1987","unstructured":"Hitchins RN, Bell DR, Woods RL, Levi JA (1987) A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5(10):1655\u20131662","journal-title":"J Clin Oncol"},{"key":"5652_CR16","doi-asserted-by":"crossref","unstructured":"Montes de Oca Delgado M, Cacho D\u00edaz B, Santos Zambrano J, Guerrero Ju\u00e1rez V, L\u00f3pez Mart\u00ednez MS, Castro Mart\u00ednez E, Avenda\u00f1o M\u00e9ndez-Padilla J, Mej\u00eda P\u00e9rez S Reyes Moreno I, Guti\u00e9rrez Aceves A, Gonz\u00e1lez Aguilar A (2018 Nov 20) The comparative treatment of intraventricular chemotherapy by Ommaya reservoir vs. lumbar puncture in patients with leptomeningeal carcinomatosis. Front Oncol 8:509","DOI":"10.3389\/fonc.2018.00509"},{"issue":"2","key":"5652_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/1759-7714.13296","volume":"11","author":"BS Kwon","year":"2020","unstructured":"Kwon BS, Cho YH, Yoon SK, Lee DH, Kim SW, Kwon DH, Lee JC, Choi CM (2020) Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor. Thorac Cancer 11(2):436\u2013442","journal-title":"Thorac Cancer"},{"issue":"2","key":"5652_CR18","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1016\/j.cllc.2022.11.011","volume":"24","author":"H Li","year":"2023","unstructured":"Li H, Zheng S, Lin Y, Yu T, Xie Y, Jiang C, Liu X, Qian X, Yin Z (2023 Mar) Safety, pharmacokinetic and clinical activity of intrathecal chemotherapy with pemetrexed via the ommaya reservoir for leptomeningeal metastases from lung adenocarcinoma: a prospective phase i study. Clin Lung Cancer 24(2):e94\u2013e104","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"5652_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5603\/pjnns.105907","volume":"60","author":"E Harahsheh","year":"2025","unstructured":"Harahsheh E, Shah S, Butterfield RJ, Ariete CC, Yancey EJ, Meyer JH, Lyons MK, Krishna C, Fortin-Ensign S, Zimmerman RS, Bendok BR, Mrugala MM (2025 Nov 5) Safety and feasibility of Ommaya reservoir for intrathecal chemotherapy in patients with leptomeningeal disease. Neurol Neurochir Pol 60(1):75\u201382","journal-title":"Neurol Neurochir Pol"},{"key":"5652_CR20","doi-asserted-by":"publisher","first-page":"153303382210784","DOI":"10.1177\/15330338221078429","volume":"21","author":"D Geng","year":"2022","unstructured":"Geng D, Guo Q, Huang S, Zhang H, Guo S, Li X (2022 Jan-Dec) A retrospective study of intrathecal pemetrexed combined with systemic therapy for leptomeningeal metastasis of lung cancer. Technol Cancer Res Treat 21:15330338221078429","journal-title":"Technol Cancer Res Treat"},{"key":"5652_CR21","doi-asserted-by":"publisher","first-page":"1545174","DOI":"10.3389\/fonc.2025.1545174","volume":"15","author":"W Zhong","year":"2025","unstructured":"Zhong W, Wu L, Qiu Z, Yu W, Liu L, Shi H, Wu S (2025 Apr 7) Intrathecal pemetrexed chemotherapy combined with systemic therapy in patients with non-small cell lung cancer and leptomeningeal metastases: a retrospective study. Front Oncol 15:1545174","journal-title":"Front Oncol"},{"issue":"24","key":"5652_CR22","doi-asserted-by":"publisher","first-page":"e40703","DOI":"10.1016\/j.heliyon.2024.e40703","volume":"10","author":"L Li","year":"2024","unstructured":"Li L, Huang Z, Chen Y, Ma H, Chen X, Yan H, Qin H, Zhang Y, Zhang X, Jiang W, Wang Z, Zhang L, Zeng F, Zhou Z, Pu X, Yang N, Zeng L, Zhang Y (2024 Dec 7) Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases. Heliyon 10(24):e40703","journal-title":"Heliyon"},{"key":"5652_CR23","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3389\/fonc.2019.00838","volume":"9","author":"Z Pan","year":"2019","unstructured":"Pan Z, Yang G, Cui J, Li W, Li Y, Gao P, Jiang T, Sun Y, Dong L, Song Y, Zhao G (2019 Aug 30) A pilot phase 1 study of intrathecal pemetrexed for refractory leptomeningeal metastases from non-small-cell lung cancer. Front Oncol 9:838","journal-title":"Front Oncol"},{"key":"5652_CR24","doi-asserted-by":"crossref","unstructured":"Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Rud\u00e0 R, Schadendorf D, Seoane J, Tonn JC, Wesseling P, Wick W, Minniti G, Peters S, Curigliano G, Preusser M (2023 Oct) EANO guidelines committee and esmo guidelines committee. Leptomeningeal metastasis from solid tumours: EANO-ESMO clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open 8(5):101624","DOI":"10.1016\/j.esmoop.2023.101624"},{"key":"5652_CR25","unstructured":"Lin G, Wang Y, Xin T, Zhang D, Zhang Q, Li Y, Chi Y, Fan Y, Liu A, Xu H, Shi L, Zhang L, Miao Q, Zheng X, Li L, Zhou K, Yao Q, Zou Z, Miao K, Hong Y (2025 Jun) Chinese expert consensus on leptomeningeal metastases of lung cancer. Thorac Cancer 16(11):e70088"},{"key":"5652_CR26","doi-asserted-by":"crossref","unstructured":"Chamberlain M, Junck L, Brandsma D, Soffietti R, Rud\u00e0 R, Raizer J, Boogerd W, Taillibert S, Groves MD, Le Rhun E, Walker J, van den Bent M, Wen PY, Jaeckle KA (2017 Apr) Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol 1(4):484\u2013492","DOI":"10.1093\/neuonc\/now183"},{"issue":"3","key":"5652_CR27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s002800050038","volume":"45","author":"FM Balis","year":"2000","unstructured":"Balis FM, Blaney SM, McCully CL, Bacher JD, Murphy RF, Poplack DG (2000) Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol 45(3):259\u2013264","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2\u20133","key":"5652_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1023\/A:1005982826121","volume":"38","author":"MC Chamberlain","year":"1998","unstructured":"Chamberlain MC (1998) Jun-Jul) Radioisotope CSF flow studies in leptomeningeal metastases. J Neuro Oncol 38(2\u20133):135\u2013140","journal-title":"J Neuro Oncol"},{"issue":"1","key":"5652_CR29","first-page":"49","volume":"47","author":"DI Sandberg","year":"2000","unstructured":"Sandberg DI, Bilsky MH, Souweidane MM, Bzdil J, Gutin PH (2000) Ommaya reservoirs for the treatment of leptomeningeal metastases. Neurosurgery 47(1):49\u201354","journal-title":"Neurosurgery"},{"issue":"2","key":"5652_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11060-015-1842-x","volume":"124","author":"F Zairi","year":"2015","unstructured":"Zairi F, Le Rhun E, Bertrand N, Boulanger T, Taillibert S, Aboukais R, Assaker R, Chamberlain MC (2015) Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients. J Neuro Oncol 124(2):317\u2013323","journal-title":"J Neuro Oncol"},{"issue":"3","key":"5652_CR31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jinf.2013.11.014","volume":"68","author":"PA Mead","year":"2014","unstructured":"Mead PA, Safdieh JE, Nizza P, Tuma S, Sepkowitz KA (2014 Mar) Ommaya reservoir infections: a 16-year retrospective analysis. J Infect 68(3):225\u2013230","journal-title":"J Infect"},{"issue":"5","key":"5652_CR32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3171\/jns.1997.87.5.0694","volume":"87","author":"MC Chamberlain","year":"1997","unstructured":"Chamberlain MC, Kormanik PA, Barba D (1997) Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 87(5):694\u2013699","journal-title":"J Neurosurg"},{"key":"5652_CR33","doi-asserted-by":"crossref","unstructured":"Wilcox JA, Chukwueke UN, Ahn MJ, Aizer AA, Bale TA, Brandsma D, Brastianos PK, Chang S, Daras M, Forsyth P, Garzia L, Glantz M, Oliva ICG, Kumthekar P, Le Rhun E, Nagpal S, O\u2019Brien B, Pentsova E, Lee EQ, Remsik J, Rud\u00e0 R, Smalley I, Taylor MD, Weller M, Wefel J, Yang JT, Young RJ, Wen PY, Boire AA (2024 Oct 3) Leptomeningeal metastases from solid tumors: a society for neuro-oncology and american society of clinical oncology consensus review on clinical management and future directions. Neuro Oncol 26(10):1781\u20131804","DOI":"10.1093\/neuonc\/noae103"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05652-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05652-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05652-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:29:37Z","timestamp":1782804577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05652-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5652"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05652-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9469387\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was not registered.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Protocol registration"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}